Results 151 to 160 of about 36,401 (249)

Diabetic Ketoacidosis and Necrotizing Soft Tissue Infection. [PDF]

J Educ Teach Emerg Med
Henschel M, Songey S.
europepmc   +1 more source

Epidemiological characteristics of ketoacidosis among Korean diabetic patients

, 1987
H K Lee, Yong‐Seok Oh, Young-Seob Chung, HyeKyoung Yoo, Seunghan Shin, Hwancheol Son, S W Kim, H C Lee, Kyuchan Huh, Yong-Suk Choi   +9 more
openalex   +1 more source

Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3176-3184, June 2025.
Abstract Aim Diabetic kidney disease (DKD) is a major complication of diabetes, including in insulin‐deficient phenotypes, yet data on kidney outcomes with sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in this population are limited. This study investigates the impact of SGLT2i on kidney outcomes in patients with insulin‐deficient diabetes using ...
Anat Tsur, Avivit Cahn, Lior Hanoch, Rena Pollack   +3 more
wiley   +1 more source

Euglycemic Diabetic Ketoacidosis in the Setting of Dulaglutide Use. [PDF]

Cureus
Patel N, Reddy A, Romero KN, Reddy P.
europepmc   +1 more source

A case of pituitary gigantism who had two episodes of diabetic ketoacidosis followed by complete recovery of diabetes.

, 1983
Takeshi Kuzuya, Ayako Matsuda, Yoshikazu Sakamoto, Kunihiro Yamamoto, Toshikazu Saito, Sho Yoshida   +5 more
openalex   +2 more sources

An unexpected ally in heart failure treatment: Unlocking the potential of sodium‐glucose cotransporter 2 inhibitors across patient subpopulations

ESC Heart Failure, Volume 12, Issue 3, Page 1532-1534, June 2025.
Sander Trenson, Mateusz Sokolski
wiley   +1 more source

Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 2920-2939, June 2025.
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab, Sam Pearson, Ramzi A. Ajjan   +2 more
wiley   +1 more source

Cerebral Edema in Diabetic Ketoacidosis [PDF]

, 2000
Arlan L. Rosenbloom
openalex   +2 more sources

Safety and clinical effectiveness of iGlarLixi in people with type 2 diabetes mellitus in Mexico

Diabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3389-3396, June 2025.
Abstract Aims To evaluate the safety and effectiveness of iGlarLixi in people with type 2 diabetes mellitus (T2DM) in clinical practice in Mexico. Materials and Methods This was a prospective, observational, multicentre study in adults with T2DM who were prescribed iGlarLixi in routine clinical practice in Mexico. The participants were followed for 24 ±
Juan Rosas‐Guzman, Alberto Navarro‐Lara, Maria Elena Sañudo‐Maury, Luis Anguiano, Leobardo Sauque‐Reyna   +4 more
wiley   +1 more source

Risk factors of acute kidney injury in children with diabetic ketoacidosis. [PDF]

BMC Nephrol
Alyahyawi N, Alghamdi D, Almahmoudi A, Sandokji I, Bokhari S, Safdar OY, Shalaby M, Shazly M, Kari JA.   +8 more
europepmc   +1 more source